Blade Air Mobility Q3 revenue $74.9M (+4.8%); net loss $(2.0)M; Adj EBITDA $4.2M

Strata Critical Medical, Inc.

2024-Q3 EPS reported -$0.23 revenue$194,336,000

Revenue $74.9M, up 4.8% YoY; gross margin improved 520 bps to 19.3%.
Net loss $(2.0)M vs income $0.3M YoY; Adjusted EBITDA $4.2M, improvement of $3.4M.
Operating cash flow $6.4M, up $4.3M; free cash flow before aircraft acquisitions $3.7M, up $2.4M.
Medical segment Adj EBITDA improved 15.1%; Passenger segment Adj EBITDA up $2.8M, achieving trailing 12-month profitability.
Reaffirmed guidance: positive Adjusted EBITDA in 2024 and double-digit millions in 2025; announced strategic alliance with OrganOx.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.